BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33218421)

  • 1. Recurrent severe placenta increta at 8 weeks of gestation in a twin pregnancy following uterus-conserving surgery for prior placenta accreta spectrum disorder.
    Chou MM; Yuan JC; Lu YA; Chuang SW
    Taiwan J Obstet Gynecol; 2020 Nov; 59(6):956-959. PubMed ID: 33218421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of placenta accreta spectrum disorder using management strategy of serial uterine artery embolization combined with standard weekly and a 8-day methotrexate/folinic acid regimens at 7 weeks of gestation.
    Chou MM; Yuan JC; Lu YA; Chuang SW
    Taiwan J Obstet Gynecol; 2020 Nov; 59(6):952-955. PubMed ID: 33218420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservative Management of Invasive Placenta Using Combined Prophylactic Internal Iliac Artery Balloon Occlusion and Immediate Postoperative Uterine Artery Embolization.
    D'Souza DL; Kingdom JC; Amsalem H; Beecroft JR; Windrim RC; Kachura JR
    Can Assoc Radiol J; 2015 May; 66(2):179-84. PubMed ID: 25797171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The recurrence risk of placenta accreta following uterine conserving management.
    Cunningham KM; Anwar A; Lindow SW
    J Neonatal Perinatal Med; 2015; 8(4):293-6. PubMed ID: 26836817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of prophylactic balloon occlusion of the internal iliac artery for the treatment of placenta accreta spectrum with placenta previa: a retrospective case-control study.
    Peng Y; Jiang L; Peng C; Wu D; Chen L
    BMC Pregnancy Childbirth; 2020 Jun; 20(1):349. PubMed ID: 32513127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative temporary occlusion of the internal iliac arteries as prophylaxis in cesarean section at risk of hemorrhage in placenta accreta.
    Carnevale FC; Kondo MM; de Oliveira Sousa W; Santos AB; da Motta Leal Filho JM; Moreira AM; Baroni RH; Francisco RP; Zugaib M
    Cardiovasc Intervent Radiol; 2011 Aug; 34(4):758-64. PubMed ID: 21598085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placenta accreta spectrum disorder: a comparison between fertility-sparing techniques and hysterectomy.
    Durukan H; Durukan ÖB; Yazıcı FG
    J Obstet Gynaecol; 2021 Apr; 41(3):353-359. PubMed ID: 32500820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of results of Bakri balloon tamponade and caesarean hysterectomy in management of placenta accreta and increta: a retrospective study.
    Pala Ş; Atilgan R; Başpınar M; Kavak EÇ; Yavuzkır Ş; Akyol A; Kavak B
    J Obstet Gynaecol; 2018 Feb; 38(2):194-199. PubMed ID: 28903630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management strategies for patients with placenta accreta spectrum disorders who underwent pregnancy termination in the second trimester: a retrospective study.
    Cui R; Li M; Lu J; Bai H; Zhang Z
    BMC Pregnancy Childbirth; 2018 Jul; 18(1):298. PubMed ID: 29996794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gravid hysterectomy following history of recurrent ruptured uterus: case report.
    Bedaiwy MA; Grob NM; Redline RW; Pinkerton J; Perriera LK; Lazebnik N
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1497-502. PubMed ID: 21599800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative Prophylactic Balloon-Assisted Occlusion of the Internal Iliac Arteries in the Management of Placenta Increta/Percreta.
    Cho SB; Hong SJ; Lee S; Won JH; Choi HC; Ha JY; Moon JI; Park JK; Park JE; Park SE
    Medicina (Kaunas); 2020 Jul; 56(8):. PubMed ID: 32717928
    [No Abstract]   [Full Text] [Related]  

  • 12. Leaving the Placenta In Situ in Placenta Accreta Spectrum Disorders: A Single-Center Case Series.
    Pineles BL; Coselli J; Ghorayeb T; Fishel Bartal M; Zvavanjanja RC; Blackwell SC; Papanna R; Sibai BM
    Am J Perinatol; 2024 May; 41(S 01):e420-e429. PubMed ID: 35752168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic use of intravascular balloon catheters in women with placenta accreta, increta and percreta.
    Cali G; Forlani F; Giambanco L; Amico ML; Vallone M; Puccio G; Alio L
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():36-41. PubMed ID: 24965977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Management of the Placenta Accreta Spectrum: An Institutional Experience.
    Mitric C; Desilets J; Balayla J; Ziegler C
    J Obstet Gynaecol Can; 2019 Nov; 41(11):1551-1557. PubMed ID: 30948337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two approaches for placenta accreta spectrum: B-lynch suture versus pelvic artery endovascular balloon.
    Frank Wolf M; Maymon S; Shnaider O; Singer-Jordan J; Maymon R; Bornstein J; Tovbin J
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2711-2717. PubMed ID: 30563387
    [No Abstract]   [Full Text] [Related]  

  • 16. Uterine rupture after prior conservative management of placenta accreta.
    Deshpande NA; Carusi DA
    Obstet Gynecol; 2013 Aug; 122(2 Pt 2):475-478. PubMed ID: 23884265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Occlusion Balloon Placement in the Abdominal Aorta Combined with Uterine or Ovarian Artery Embolization for the Prevention of Cesarean Hysterectomy Due to Placenta Accreta: A Retrospective Study.
    Liu J; Wang Y; Jiao D; Zhang W; Han X
    Cardiovasc Intervent Radiol; 2019 Jun; 42(6):829-834. PubMed ID: 30701289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the holding-up uterus technique for placenta accreta spectrum cesarean hysterectomy in shocked patients with a high shock index: a case series study.
    Takahashi J; Orisaka M; Inoue D; Kawamura H; Takahashi N; Tsuyoshi H; Shinagawa A; Kurokawa T; Yoshida Y
    BMC Surg; 2024 Jan; 24(1):23. PubMed ID: 38218800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic intraoperative uterine artery embolization to control hemorrhage in abnormal placentation during late gestation.
    Yu PC; Ou HY; Tsang LL; Kung FT; Hsu TY; Cheng YF
    Fertil Steril; 2009 May; 91(5):1951-5. PubMed ID: 18501901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Maternal morbidity and mortality associated with conservative management for placenta morbidly adherent (accreta) diagnosed during pregnancy. Report of 15 cases].
    Daney de Marcillac F; Lecointre L; Guillaume A; Sananes N; Fritz G; Viville B; Boudier E; Nisand I; Gaudineau A; Langer B; Akladios CY
    J Gynecol Obstet Biol Reprod (Paris); 2016 Oct; 45(8):849-858. PubMed ID: 27118678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.